Prognostic value of the CALLY and triglyceride-glucose indices in non-diabetic NSTEMI with multivessel disease: the role of revascularization completeness
Year: 2026
Type: article
Study design: Observational Study
Abstract: Background The triglyceride-glucose (TyG) and C-reactive protein-albumin-lymphocyte (CALLY) indices reflect metabolic and inflammatory-nutritional risk, but their prognostic value in non-diabetic patients with non-ST-elevation myocardial infarction (NSTEMI) and multivessel disease, and whether this value depends on revascularization status, is unknown. We examined the association of both indices with one-year major adverse cardiovascular events (MACE) and their incremental value over the GRACE score. Methods We retrospectively studied 1,424 non-diabetic NSTEMI patients with multivessel disease, of whom 738 (51.8%) underwent complete revascularization (CR) and 686 (48.2%) incomplete revascularization (ICR). The prognostic value of each index was assessed by ROC analysis, Kaplan–Meier survival, and Cox regression, and their incremental value over GRACE by reclassification metrics. Results MACE occurred in 174 patients (12.2%) over one year. The CALLY index predicted risk in both groups, with an approximately fourfold risk in the lowest versus the highest tertile (adjusted HR 4.23), and its effect did not vary with revascularization status (interaction p = 0.40). The prognostic association of TyG appeared to differ by revascularization status: it was significant after CR (HR 2.66) but not after ICR (HR 1.42), although the interaction did not reach significance ( p = 0.070). Adding both indices improved discrimination beyond GRACE (C-index 0.694 to 0.743; continuous net reclassification improvement 0.259 for CALLY). Conclusion In non-diabetic NSTEMI with multivessel disease, the CALLY index is a revascularization-independent prognostic marker, whereas the prognostic value of the TyG index appeared mainly in patients with complete revascularization, suggesting a possible trend toward effect modification that requires confirmation. Interpreted in the context of revascularization, these two readily available indices may refine risk stratification beyond the GRACE score.
Authors: Metin Karayakali(Conceptualization, Formal analysis, Investigation, Methodology, Project administration, Resources, Software, Supervision, Validation, Visualization, Writing – original draft, Writing – review & editing), Samet Yılmaz(Conceptualization, Formal analysis, Supervision, Writing – review & editing), Gülşen Genç Tapar(Resources, Software, Supervision, Validation, Visualization, Writing – review & editing), Gökhan Cabri(Data curation, Investigation, Resources, Writing – original draft), Volkan Yılmaz(Data curation, Investigation, Software, Validation, Writing – review & editing), Veli Akın(Data curation, Resources, Validation, Writing – original draft), Arif Arısoy(Methodology, Resources, Supervision, Writing – review & editing)
Institutions: Tokat Gaziosmanpaşa Üniversitesi, Başkent University
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: CALLY index, triglyceride-glucose index, non-ST-elevation myocardial infarction, multivessel coronary artery disease, revascularization completeness, major adverse cardiovascular events, risk stratification, GRACE risk score, C-reactive protein, albumin, lymphocyte count, metabolic risk markers
Open Access status: gold
Estimated APC paid: $3,801
OpenAlex ID: W7236026720
